| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 2.468 | 4.416 | 6.888 | 12.424 | 15.887 |
| Total Income - EUR | - | - | - | - | - | 2.468 | 4.416 | 6.888 | 12.424 | 15.887 |
| Total Expenses - EUR | - | - | - | - | - | 1.676 | 3.681 | 5.758 | 12.680 | 15.815 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 791 | 735 | 1.130 | -257 | 71 |
| Net Profit/Loss - EUR | - | - | - | - | - | 718 | 602 | 923 | -257 | 60 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Renalmed Plus S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 1.503 | 1.817 | 2.912 | 6.557 | 6.357 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 492 | 547 | 0 | 1.961 | 0 |
| Cash | - | - | - | - | - | 1.012 | 1.270 | 2.912 | 4.595 | 6.357 |
| Shareholders Funds | - | - | - | - | - | 759 | 1.344 | 2.272 | 2.008 | 2.057 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 744 | 2.994 | 3.170 | 4.549 | 4.300 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Renalmed Plus S.r.l.